neovascular glaucoma
Conditions
Interventions
experimental group:The experimental valve inserted
Sponsors
Shanghai Tongji Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Male and female aged 18 years; 2. The subjects had clinical manifestations of neovascular glaucoma; 3. The researchers determine need to use valves implanted the operation way of subjects; 4. Participants can't anterior chamber implantation valve: Anterior chamber depth< 2 mm; anterior chamber around the narrow corner < 1/2 CT; 5. The participants or their legal representatives to understand the research purpose, according to the research plan enough compliance, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. There are eyes neovascular glaucoma, and treatment of the subjects at the same time;Acute infectious eye disease subjects; Eye malignant tumor of the subjects; 2. There are serious refractive stromal opacity and may affect the operation of the subjects; 3. There are important viscera function failure or other serious disease, including clinical related coronary artery disease, Cardiovascular disease or myocardial infarction into the group of the first six months; Serious neurological or psychiatric illness; Serious infections; Coagulant function abnormality; There general active infectious diseases; 4. The subject participate in drug test or other medical instrument clinical trial subjects before 1 months; 5. Patients with mental illness to interfere with treatment and assessment; 6. Breastfeeding women or pregnant women; 7. 3 months prior to screening to participate in any clinical study or researchers think not suitable to participate in this clinical trial subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraocular pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| new vessels; | — |
Countries
China
Contacts
Public ContactAo Rong
Shanghai Tongji Hospital
Outcome results
None listed